Q1 2024 Atomo Diagnostics Ltd Activities Report Call Transcript
Good morning, everyone. My name is John Kelly, I'm the Managing Director for Atomo Diagnostics, and welcome to this our first-quarterly activity statement for the new FY24. I'm going to very briefly talk to some of the key highlights for the quarter. Well, then jump into each of those main activities and drivers of growth and go through that a little bit more detail. We will then wrap up the presentation by quickly summarizing the key areas of focus for the coming months, and then we'll look to move to a Q&A session at the end, and please feel free to put any questions into the webinar box, and we'll move forward with those at the end of the presentation.
So in terms of highlights for the quarter. Obviously, we're very pleased to see a resumption of growth in the HIV business 176,000 tests. So during the period that primarily Newfoundland Diagnostics in the UK that's becoming a very important relationship for us. And we've expanded that to now include Colombia as another country that they're entering on our behalf and we're in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
